相关实验视频
Updated: Feb 14, 2026

05:39
Murine Model of Wound Healing
Published on: May 28, 2013
67.6K
加拿大大麻素受体1的激活通过促进增殖阶段来增强伤口愈合
Hui Song Cui1, Ya Xin Zheng1, Yoon Soo Cho2
1Burn Institute, Department of Rehabilitation Medicine, Hangang Sacred Heart Hospital, College of Medicine, Hallym University, 94-200 Yeongdeungpo-Dong, Yeongdeungpo-Ku, Seoul 07247, Republic of Korea.
International journal of molecular sciences
|February 13, 2026
概括
激活大麻素受体1 (CB1) 显著增强伤口愈合. 在实验室和动物模型中,CB1激动剂促进纤维细胞活性并加速皮肤修复,表明治疗潜力.
科学领域:
- 细胞生物学 细胞生物学
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 大麻素受体1 (CB1) 已知具有神经调节功能.
- CB1在伤口愈合机制中的特定作用尚未完全理解.
研究的目的:
- 研究激活CB1对伤口愈合过程的影响.
- 探索CB1激动剂在伤口治疗中的治疗潜力.
主要方法:
- 在实验室内:用CB1激动剂2-arachidonyl glyceryl ether (2-AGE) 治疗的人体皮肤纤维细胞.
- 在体内:小鼠急性伤口模型用CB1激动剂阿拉基多诺伊尔2'-chloroethylamide (ACEA).
- 对细胞增殖,分化,迁移和关键蛋白质 (α-SMA,原蛋白,纤维蛋白) 的表达进行分析.
主要成果:
- 在体外:2-AGE增加了纤维细胞的增殖,分化,迁移和原/纤维蛋白合成.
- 在体内:ACEA加速了伤口关闭,增加了α-SMA,原蛋白和纤维素的表达,增强了皮肤厚度.
- 在实验室中,CB1抗剂AM251逆转了2-AGE诱导的影响.
结论:
- CB1激活促进了参与伤口愈合的关键细胞过程.
- CB1激动剂显示出加速伤口修复的治疗潜力.
相关概念视频
Proliferative Phase
1.5K
The proliferative phase typically occurs after menstruation and lasts between 6 to 13 days in a standard 28-day cycle. This phase involves the reconstruction of the endometrium, guided by estrogen produced by the developing ovarian follicle.
Notably, the stratum basale, the basal layer of the endometrium, including the basal parts of the uterine glands, remains unaffected by menstruation. Stem cells in this layer undergo mitosis, regenerating the stratum functionalis and thickening the...
Notably, the stratum basale, the basal layer of the endometrium, including the basal parts of the uterine glands, remains unaffected by menstruation. Stem cells in this layer undergo mitosis, regenerating the stratum functionalis and thickening the...
1.5K
Phases of Wound Repair
8.5K
Following injury, the integrity of the injured tissues must be reestablished. For example, in skin tissue, wound repair involves coordination among resident skin cells, blood mononuclear cells, extracellular matrix, growth factors, and cytokines to complete the healing cascade.
Formation of Blood Clot
In case of deep injuries, trauma to blood vessels results in blood loss. In the meantime, phospholipids released from the ruptured endothelial cellular membrane are converted into arachidonic...
Formation of Blood Clot
In case of deep injuries, trauma to blood vessels results in blood loss. In the meantime, phospholipids released from the ruptured endothelial cellular membrane are converted into arachidonic...
8.5K
Internal Receptors
74.7K
Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
74.7K
The Eukaryotic Promoter Region
19.0K
The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences. The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
19.0K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
663
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
663
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
649
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
649

